Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward, is at the center of the discussion of healthcare and real-world data in a recent NetworkNewsAudio release. The broadcast, titled “Real-World Data, Point-of-Care Testing Reshaping Healthcare, Detecting Diseases Sooner,” notes that insurers, healthcare providers, life sciences companies and governments alike face challenges such as rising costs and inconsistent outcomes. Evidence points toward real-world data, which is more accurate and cost efficient, making a positive impact on these challenges. The audio broadcast also mentioned that younger generations of patients are becoming more involved in their healthcare, increasing the demand for data-driven care. The discussion also mentioned pressure that pharmacies are feeling from regulators, competition and industry. As a pharmacy service innovator focused on acquiring and developing early-stage technologies, Avricore is in a prime position to move pharmacy forward as it commercializes an eponymous product that is unlike anything in pharmacies today.
To view the full press release, visit
https://ibn.fm/KHMEt
About Avricore Health Inc.
Avricore Health is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab(TM), a wholly owned subsidiary, the company’s mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. For more information about the company, please visit
www.AvricoreHealth.com
NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at
https://ibn.fm/AVCRF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.